Zenosense, Inc.: Breakthrough Quantitative MIDS Testing Results

Press release Jun 19, 2018 OTC Disclosure & News Service Breakthrough Quantitative MIDS Testing Results VALENCIA, SPAIN, June 19, 2018; Zenosense, Inc. (OTC PINK: ZENO) (“Zenosense”, the “Company”), a healthcare technology company focused on the development and commercialization of the MIDS Cardiac™ hand-held technology for the early detection of heart attack at the Point of…